This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Ingelheim Pharma Gmbh & Co Kg. Active years: 2007-2008.
Company Filing History:
Years Active: 2007-2008
Title: Innovations of Hans-Peter Ignatow
Introduction
Hans-Peter Ignatow is a notable inventor based in Ingelheim, Germany. He has made significant contributions to the field of chemistry, particularly in the development of processes for synthesizing complex compounds. With a total of 2 patents to his name, Ignatow's work has implications in pharmaceuticals and organic chemistry.
Latest Patents
Ignatow's latest patents include a process for preparing N-substituted 3-β-aminonortropanes. This invention details a method for synthesizing these compounds from 3-oxonortropane or 3α-aminonortropane, utilizing arylmethylamine or arylaldehyde to form imines that are subsequently tautomerized or isomerized and hydrolyzed. Additionally, he has developed a process for isolating α-mangostin, which involves obtaining and purifying this compound from the rind of the mangosteen fruit.
Career Highlights
Hans-Peter Ignatow is affiliated with Boehringer Ingelheim Pharma GmbH & Co. KG, a leading global pharmaceutical company. His work at this institution has allowed him to focus on innovative chemical processes that contribute to the development of new therapeutic agents.
Collaborations
One of his notable collaborators is Rainer Sobotta, with whom he has worked on various projects related to his patents. Their partnership has fostered advancements in their respective fields.
Conclusion
Hans-Peter Ignatow's contributions to the field of chemistry through his patents reflect his innovative spirit and dedication to advancing pharmaceutical science. His work continues to influence the development of new compounds and processes in the industry.